Android app on Google Play

AMRI (AMRI) to Close Bothell Site

November 30, 2012 8:03 AM EST Send to a Friend
Get Alerts AMRI Hot Sheet
Price: $16.47 -0.9%

Financial Fact:
Recurring royalties: 7.41M

Today's EPS Names:
LO, BOLT, CSH, More
Trade AMRI Now!
Join SI Premium – FREE
AMRI (Nasdaq: AMRI) announced today that as a next step in its SMARTSOURCING strategy it has taken further actions to expand and better integrate its in vitro biology services with its total drug discovery service platform.

As a result of shifting market preferences related to integrated drug discovery activities, AMRI will further optimize its location footprint by closing its Bothell, WA site. The site's biology capabilities will transition to AMRI's fully integrated discovery location in Singapore and certain analytical capabilities will consolidate into AMRI's analytical quality group in Albany, N.Y. The Bothell, WA location employs 24 people.

AMRI estimates that it will incur certain one-time cash and non-cash charges related to the reduction in force and other transition activities of approximately $11 million, of which approximately $5 million in non-cash charges will be incurred in the fourth quarter. AMRI expects the actions announced today will generate annual savings of approximately $2 million. Further details will be available in a Form 8-K filing.




You May Also Be Interested In


Related Categories

Corporate News, FDA, Guidance

Add Your Comment